Navigation Links
Help for Psoriasis

New research shows the drug efalizumab may reduce symptoms of psoriasis and improve patients’ quality of life.//

Researchers from Loyola University studied more than 550 patients who had psoriasis. Patients received weekly injections of efalizumab (Raptiva) or a placebo for three months. Researchers evaluated the extent of each patient’s condition and rated the degree of scaling and thickness. Patients also completed a questionnaire that measured their quality of life and severity of symptoms.

Results of the study show patients who received efalizumab experienced a significant improvement in their symptoms and quality of life. Patients were considered to have improved if they scored at least 75 percent on the Psoriasis Area and Severity Index. Twenty-seven percent of the patients treated with efalizumab scored at least 75 percent, while only 4 percent of patients in placebo group achieved this score. Patients who took efalizumab also reported a better quality of life than those in the placebo group.

Efalizumab is a biologic drug that blocks immune cells. Researchers say the drug modulates T-cells, which bolster the body’s immune response. Kenneth Gordon, M.D., from the Loyola Psoriasis Center, says, “Biologics are injected, instead of swallowed and block immune cells that produce the dry, flaky skin.”

Psoriasis is triggered by an immune system response that causes skin cells to grow too quickly. The skin cells do not mature normally, and the skin piles up, causing red, scaly lesions to form. About 5 million people in the United States are affected by psoriasis. There is currently no cure, but researchers say new treatments, including biologics, are helping to improve the condition for many patients.

'"/>




Page: 1

Related medicine news :

1. New and unique treatment for Psoriasis patients
2. Comparing Psoriasis Treatments
3. Psoriasis Increases Cancer Risk
4. Managing Patients With Psoriasis
5. Effective Treatment Option For Psoriasis
6. Smoking Aggravates Psoriasis
7. Remicade Emerges as a Treatment for Patients Suffering From Psoriasis Disorder
8. Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis
9. Psoriasis raises risk for heart attack
10. Psoriasis Associated With Increased Risk For Heart Attack
11. Remicade Therapy Effective in Treating Severe Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... While it’s ... poses a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , ... medication in darkness or restricted lighting. As such, it eliminates the need to turn ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... http://www.rebound-solution.com/ ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
Breaking Medicine Technology: